ΔΗΜΟΣΙΕΥΣΕΙΣ
PUBLIC
Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening.
Kimon Chatzistamatiou , Theodoros Moysiadis, Viktoria Moschaki , Nikolaos Panteleris , Theodoros Agorastos
03 Νοε 20
12:58 ΜΜ
Effect of mode of delivery on vertical human papillomavirus transmission - A meta-analysis.
K Chatzistamatiou, A Sotiriadis , T Agorastos
03 Νοε 20
1:04 ΜΜ
PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis.
Christos Nikolaidis, Evangelia Nena , Maria Panagopoulou , Ioanna Balgkouranidou , Makrina Karaglani, Ekaterini Chatzaki , Theodoros Agorastos, Theodoros C Constantinidis
03 Νοε 20
1:08 ΜΜ
Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology
Agorastos T, Chatzistamatiou K, Katsamagkas T, Koliopoulos G, Daponte A, Constantinidis T, Constantinidis TC; HERMES study group.
19 Αυγ 20
3:42 ΜΜ
Distinct demographic factors influence the acceptance of vaccination against HPV.
Agorastos T, Chatzistamatiou K, Zafrakas M, Siamanta V, Katsamagkas T, Constantinidis T, Lampropoulos A; Lysistrata Study Group.
28 Αυγ 20
1:37 ΜΜ
Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study
Agorastos T, Chatzistamatiou K, Zafrakas M, Siamanta V, Katsamagkas T, Constantinidis TC, Lampropoulos AF; LYSISTRATA study group.
19 Αυγ 20
3:44 ΜΜ
